Fundamental dimension Equity attribute | ADPPeer $287.03▼-0.65% Cap $113.7BP/E 26.2x QuantScore45/100 | ASURLeader $7.26▼-1.29% Cap $209.5MP/E -25.2x QuantScore54/100 | BBSIPeer $33.22▲+1.25% Cap $805.1MP/E 23.9x QuantScore51/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
84/100 |
46/100 |
84/100 |
Valuation Multiples, PEG & DCF upside | 58/100 | 45/100 | 51/100 |
Health Piotroski, Altman Z, leverage & liquidity | 33/100 | 30/100 | 65/100 |
Growth Revenue / earnings growth & margins | 31/100 | 48/100 | 18/100 |
Sentiment Analyst ratings, targets & revisions | 19/100 | 99/100 | 37/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 26.2x | -25.2x | 23.9x |
Forward P/E (next FY) | 23.4x | 8.4x | 24.8x |
EV / EBITDA (TTM) | 17.8x | 9.1x | 11.6x |
Price / Sales | 5.2x | 1.3x | 0.6x |
Price / Free Cash Flow | 22.8x | 19.1x | 51.9x |
PEG ratio | 2.73 | -0.36 | -0.72 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 6 / 9 | 5 / 9 | 6 / 9 |
Altman Z-Score | 1.66 (Distress) | -0.16 (Distress) | 3.44 (Safe) |
Total debt / equity | 0.87 | 0.38 | 0.12 |
Quick ratio | 0.2x | 1.1x | 1.1x |
Interest coverage | 8.9x | -0.2x | 629.4x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +6.7% | +17.3% | +8.4% |
Net income growth YoY | +8.2% | -11.5% | +2.7% |
Gross margin (TTM) | 48.2% | 68.1% | 19.8% |
Operating margin (FY) | 18.6% | -6.0% | 5.0% |
FCF margin (FY) | 23.9% | 15.2% | 3.8% |
5. Trailing price performancePrice change over period |
1M return | +5.8% | -8.2% | +5.1% |
3M return | +12.4% | -3.8% | -16.4% |
6M return | +43.2% | -19.7% | +9.0% |
Year to date | +11.6% | -23.0% | -8.3% |
1Y return | +1.4% | -14.2% | -20.9% |
3Y return | +16.6% | -13.5% | +51.3% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $292.02 +1.7% upside | $-3.56 -149.0% premium | $24.98 -24.8% premium |
Wall Street consensus target | $267.67 -6.7% · range $225.00–$310.00 | $14.75 +103.3% · range $11.00–$20.00 | $40.00 +20.4% · range $38.00–$44.00 |
Consensus stance | 22% Buy64% Hold14% Sell | 89% Buy6% Hold6% Sell | 60% Buy40% Hold0% Sell |